Table 1.
Characteristics of diabetes patients of 95 physicians randomised to intervention (n=48) or control (n=47) who completed follow-up
| Patient characteristic | Baseline |
Follow-up |
||||
|---|---|---|---|---|---|---|
| Intervention (n=715) | Control (n=467) | Total (n=1182) | Intervention (n=479) | Control (n=466) | Total (n=945) | |
| Age (years) | 58.7 (13.59) | 60.6 (13.79) | 59.4 (13.70) | 61.3 (13.42) | 60.5 (12.71) | 60.9 (13.09) |
| Gender, female | 360 (51.1%) | 230 (49.5%) | 590 (50.5%) | 260 (54.5%) | 252 (54.4%) | 512 (54.5%) |
| Race, African American | 97 (13.9%) | 99 (21.3%) | 196 (16.9%) | 102 (21.4%) | 143 (30.9%) | 245 (26.1%) |
| Obesity* | 274 (38.3%) | 193 (41.3%) | 467 (39.5%) | 97 (20.3%) | 75 (16.1%) | 172 (18.2%) |
| Smoker, current | 85 (12.5%) | 55 (12.3%) | 140 (12.4%) | 63 (13.8%) | 53 (13.0%) | 116 (13.4%) |
| No self-testing | 168 (33.6%) | 114 (36.3%) | 282 (34.6%) | 189 (41.4%) | 183 (44.7%) | 372 (43.0%) |
| Non-adherence to appointments | 75 (11.0%) | 54 (12.0%) | 129 (11.4%) | 10 (2.2%) | 23 (5.6%) | 33 (3.8%) |
| Insurance, Medicaid | 65 (9.1%) | 51 (10.9%) | 116 (9.8%) | 66 (13.8%) | 58 (12.4%) | 124 (13.1%) |
| Comorbidities | ||||||
| Diabetes complications† | 147 (20.6%) | 110 (23.6%) | 257 (21.7%) | 156 (32.6%) | 134 (28.8%) | 290 (30.7%) |
| Insulin use | 103 (14.4%) | 66 (14.1%) | 169 (14.3%) | 84 (17.5%) | 68 (14.6%) | 152 (16.1%) |
| Hypertension | 473 (66.2%) | 304 (65.1%) | 777 (65.7%) | 327 (68.3%) | 283 (60.7%) | 610 (64.6%) |
| Hyperlipidaemia | 110 (15.4%) | 85 (18.2%) | 195 (16.5%) | 11 (2.30%) | 17 (3.7%) | 28 (3.0%) |
| Peripheral vascular disease | 47 (6.6%) | 31 (6.6%) | 78 (6.6%) | 41 (8.6%) | 35 (7.5%) | 76 (8.0%) |
| Coronary artery disease | 135 (18.9%) | 83 (17.8%) | 218 (18.4%) | 111 (23.2%) | 95 (20.4%) | 206 (21.8%) |
| Vascular intervention‡ | 60 (8.4%) | 47 (10.1%) | 107 (9.1%) | 36 (7.5%) | 40 (8.6%) | 76 (8.0%) |
| Depression | 105 (14.7%) | 61 (13.1%) | 166 (14.0%) | 84 (17.5%) | 60 (12.9%) | 144 (15.2%) |
A prior version of this table has been reported (reproduced with permission).15
Values are mean (SD) or n (%).
*Obesity: body mass index ≥ 30 kg/m2 or clinical diagnosis.
†Diabetes complications: retinopathy, neuropathy or nephropathy.
‡Vascular intervention: coronary artery bypass grafting, stent, percutaneous coronary angioplasty.